Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation (NCT06971575) | Clinical Trial Compass
RecruitingNot Applicable
Cervical Radiculopathy Imaging Using MRN With Electrodiagnostic Correlation
United States20 participantsStarted 2023-10-24
Plain-language summary
This project will study patients with cervical radiculopathy. We will evaluate the combined diagnostic and prognostic value of magnetic resonance neurography (MRN), electrodiagnostic (EDX) studies, and historical and physical clinical elements. Specifically, this project will explore whether these data individually or in combination correlate with response to procedural and non-procedural treatment.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients presenting with symptoms compatible with acute or subacute unilateral (one-sided) cervical radiculopathy and signs of clinical weakness
* 18-60 years old at the time of evaluation
* Symptom onset of 2 to 12 weeks leading up to baseline visit
* Diagnosis of unilateral cervical radiculopathy, with or without spinal cord compression, based on signs and symptoms, physical exam and supported by MRI findings of radiculopathy (as evidenced by foraminal stenosis/narrowing) based on standard-of-care cervical spine MRI
* Patients who have undergone or have planned electrodiagnostic testing at HSS prior to surgery
Exclusion Criteria:
* Prior cervical surgery or instrumentation
* Those who have had a prior episode of cervical radiculopathy
* History of peripheral neuropathy or another acute or chronic neurodegenerative condition
* History of stroke, cerebellar disease, or central nervous system disease
* Contraindications to undergoing a standard MRI examination (e.g., pregnancy)
* Patients presenting with bilateral cervical radiculopathy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Presence of abnormalities on nerve (MRN) imaging
Timeframe: Baseline
2
Relationship between abnormalities on imaging and electrodiagnostic assessment